Serum levels of different tumour markers in patients with chronic heart failure

European Journal of Heart Failure

Volumn 7, Issue 1, 2005, Pages 57-61

  Faggiano, Pompilio ^a   D'Aloia, Antonio ^a   Brentana, Loretta ^a   Bignotti, Tommaso ^a   Fiorina, Claudia ^a   Vizzardi, Enrico ^a   Dei Cas, Livio ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Carbohydrate antigen 125; Heart failure; Tumour markers

Indexed keywords

ALPHA FETOPROTEIN; CARBOHYDRATE ANTIGEN; CARBOHYDRATIC ANTIGEN 125; CARBOHYDRATIC ANTIGEN 15.3; CARBOHYDRATIC ANTIGEN 19.9; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; DRUG RESPONSE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TUMOR MARKERS, BIOLOGICAL; VENTRICULAR FUNCTION, LEFT;

EID: 11844297800     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2004.04.009     Document Type: Article

References (18)

1. Francis G.S., Cohn J.N., Johnson G., Rector T.S., Goldman S., Simon A. Plasma norepinephrine, plasma renin activity and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative studies group. Circulation. 87:1993;VI140-148
2. Cheng V., Kazanegra R., Garcia A., et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol. 37:2001;368-391
3. Sharma R., Rauchhaus M., Ponikowski P.P., et al. The relationship of the erythrocyte sedimentation rate to inflammatory cytokines and survival in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. J Am Coll Cardiol. 36:2000;523-528
4. Ferrari R., Bachetti T., Confortini R., et al. Tumor necrosis factor solubile receptors in patients with various degree of congestive heart failure. Circulation. 92:1995;1479-1486
5. MacGowan G.A., Mann D.L., Kormos R.L., Feldman A.M., Murali S. Circulating interleukin-6 in severe heart failure. Am J Cardiol. 79:1997;1128-1131
6. Nagele H., Bahlo M., Klapdor R., Schaeperkoetter D., Rodiger W. CA 125 and its relation to cardiac function. Am Heart J. 137:1999;1044-1049
7. D'Aloia A., Faggiano P., Aurigemma G.P., Bontempi L., Ruggeri G., Metra M., et al. Serum levels of carbohydrate antigen 125 (CA 125) in patients with chronic heart failure. Relation with clinical severity, hemodynamic and Doppler echocardiographic abnormalities and short term prognosis. J Am Coll Cardiol. 41:2003;1805-1811
8. Helmcke F., Nanda N.C., Hsiung M.C., et al. Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation. 75:1987;175-183
9. Giannuzzi P., Imparato A., Temporelli P.L., et al. Doppler-derived mitral deceleration time of early filling as a strong predictor of pulmonary capillary wedge pressure in postinfartion patients with left ventricular systolic dysfunction. J Am Coll Cardiol. 23:1994;1760-1767
10. Bast R.C., Klug T.L., John E.S., et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med. 309:1983;883-887
11. O'Brien T.J., Tanimoto H., Konishi I., Gee M. More than 15 years of CA 125: what is known about the antigen, its structure and its function. Int J Biol Markers. 13:1998;188-195
12. Bates S.E. Clinical applications of serum tumor markers. Ann Intern Med. 115:1991;623-638
13. Sjovall K., Nilsson B., Einhorn N. The significance of serum CA 125 elevation in malignant and non-malignant diseases. Gynecol Oncol. 85:2002;175-178
14. Bergmann J.F., Bidart J.M., George M., Beaugrand M., Levy V.G., Bohuon C. Elevation of CA 125 in patients with benign and malignant ascites. Cancer. 59:1987;213-217
15. Sevinc A., Buyukberger S., Sari R., Kiroglu Y., Turk H.M., Ates M. Elevated serum CA-125 in hemodialysis patients with peritoneal, pleural or pericardial fluids. Gynecol Oncol. 77:2000;254-257
16. Zeimet A.G., Offner F.A., Marth C., et al. Modulation of CA 125 release by inflammatory cytokines in human peritoneal mesothelial and ovarian cancer cells. Anticancer Res. 17:1997;3129-3131
17. Kubonishi I., Bandobaschi K., Murata N., Daibata M., Ido E., Sonobe H. High serum levels of CA 125 and interleukin-6 in a patient with Ki-1 lymphoma. Br J Haematol. 98:1997;450-452
18. Marth C., Zeimet A.G., Widschwendter M., Daxenbichler G. Regulation of CA 125 expression in cultured human carcinoma cells. Int J Biol Markers. 13:1998;207-209